Quarterly report · Q2
3101.TEDINET S100S6NA
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥199.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥399.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥201.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥7.9bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.0bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥6.6bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.8bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥3.1bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥14.8bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.0bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥655m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.6bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥11.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥577.2bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥588.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥541.2bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥355.4bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥367.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥221.8bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥221.4bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥207.0bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥29.9bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥60.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥29.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥60.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥28.1bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥26.4bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥26.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥36.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥16.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥15.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥61.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥5.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥22.82 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.6 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.37 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.35 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.67 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 33.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥14.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥4.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥9.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥411m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥16.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥16.7bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥2.4bn |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥16.6bn |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥16.6bn |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥7m |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥582m |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥971m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥201.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥194.8bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥7.1bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥216.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥199.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥16.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥4.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥12.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥7.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥184m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥10.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥10.6bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥1.9bn |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥19.3bn |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥19.3bn |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥17m |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥5.4bn |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥2.2bn |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥188m |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥805m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥199.5bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥196.8bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2.7bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥9.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥211.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥201.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥10.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥9.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 515
| Item | Context | Value | Unit |
|---|---|---|---|
| Current liabilities | CurrentQuarterInstant | 181664000000 | JPY |
| Bonds payable | Prior1YearInstant | 65000000000 | JPY |
| Bonds payable | CurrentQuarterInstant | 50000000000 | JPY |
| Long term loans payable | Prior1YearInstant | 49099000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 74329000000 | JPY |
| Deferred tax liabilities for land revaluation | Prior1YearInstant | 19641000000 | JPY |
| Deferred tax liabilities for land revaluation | CurrentQuarterInstant | 19641000000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 239000000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 246000000 | JPY |
| Provision for environmental measures ncl | Prior1YearInstant | 12000000 | JPY |
| Provision for environmental measures ncl | CurrentQuarterInstant | 11000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 22427000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 21922000000 | JPY |
| Other ncl | Prior1YearInstant | 8566000000 | JPY |
| Other ncl | CurrentQuarterInstant | 7594000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 164984000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 173744000000 | JPY |
| Liabilities | Prior1YearInstant | 367484000000 | JPY |
| Liabilities | CurrentQuarterInstant | 355408000000 | JPY |
| Capital stock | Prior1YearInstant | 51730000000 | JPY |
| Capital stock | CurrentQuarterInstant | 51730000000 | JPY |
| Capital surplus | Prior1YearInstant | 32402000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 33187000000 | JPY |
| Retained earnings | Prior1YearInstant | 70490000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 68967000000 | JPY |
| Treasury stock | Prior1YearInstant | -781000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -1005000000 | JPY |
| Shareholders equity | Prior1YearInstant | 153840000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 152880000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 3434000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 1475000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | 67000000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | 163000000 | JPY |
| Revaluation reserve for land | Prior1YearInstant | 41435000000 | JPY |
| Revaluation reserve for land | CurrentQuarterInstant | 41435000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -4556000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | -1257000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -4632000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | -4365000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 35748000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 37452000000 | JPY |
| Non controlling interests | Prior1YearInstant | 31834000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 31462000000 | JPY |
| Net assets | Prior1YearInstant | 221422000000 | JPY |
| Net assets | CurrentQuarterInstant | 221793000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 588906000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 577201000000 | JPY |
| Net sales | Prior1YTDDuration | 201123000000 | JPY |
| Net sales | CurrentYTDDuration | 199419000000 | JPY |
| Cost of sales | Prior1YTDDuration | 155942000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |